Differential DNA damage response to WRN inhibition identifies a targetable vulnerability in ARID1A-mutated cancers
Kim, J.; Oh, J.; Jang, D.; Shin, S.; Lee, S.-J.; Lee, S. E.; Yang, Y.; Kim, D.; Choi, A.-J.; Jung, H. R.; Oh, Y.; Cho, S.-Y.
Show abstract
ARID1A, a key subunit of the SWI/SNF chromatin remodeling complex, is frequently mutated in cancers. However, effective clinical treatments for patients with this mutation are limited, highlighting a demand for new therapeutic strategies. Here, we establish Werner syndrome ATP-dependent helicase (WRN) as a critical vulnerability target in ARID1A-mutated cancers. Upon genetic and pharmacological inhibition of WRN, ARID1A-mutated cells had defective Chk1-mediated DNA damage signaling, resulting in compensatory Chk2 activation, leading to G1-phase arrest and apoptosis, whereas ARID1A-proficient cells underwent Chk1-dependent G2/M arrest. Additional p21 inhibition, combined with WRN suppression, drove G1-arrested cells to re-enter the cell cycle, triggering mitotic catastrophe. The anti-tumor efficacy of WRN inhibition was validated using in vivo cell lines and patient-derived xenograft mouse models. Our findings define WRN as a selective therapeutic target in ARID1A-mutated cancers and suggest a combinatorial strategy of WRN and p21 inhibition as a therapeutic approach.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Increased RNA and protein degradation is required for counteracting transcriptional burden and proteotoxic stress in human aneuploid cells 97%
- FH variant pathogenicity promotes purine salvage pathway dependence in kidney cancer 96%
- An immunomechanical checkpoint PYK2 governs monocyte-to-macrophage differentiation in pancreatic cancer 96%
Similar papers in this journal
- CIP2A interacts with TopBP1 and is selectively essential for DNA damage-induced basal-like breast cancer tumorigenesis 96%
- EZH2 synergizes with BRD4-NUT to drive NUT carcinoma growth through silencing of key tumor suppressor genes 96%
- Inhibiting DDX3X triggers tumor-intrinsic type I interferon response and enhances anti-tumor immunity 96%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.